February 9, 2021 | Compliance An Analysis Of MHRA’s Latest Annual GMP Inspection Deficiencies Report Are you aware of recent changes from EMA pertaining to manufacturers of chemically synthesized drugs and biological products? Barbara Unger Principal Consultant 10 Minute Read